Beverly Green, MD, MPH, is a physician-scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow—and easier for providers to deliver.
Dr. Green’s research has a strong public health focus, targeting conditions that affect large proportions of the population, such as cardiovascular disease, cancer, and obesity. She also emphasizes leveraging technologies and systems-based care.
In 2016 Dr. Green launched the BP-CHECK study, which aims to find the easiest, most accurate way to diagnose high blood pressure. With a $2.8 million award from the Patient-Centered Outcomes Research Institute (PCORI), the study will compare blood pressure readings taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension.
Dr. Green’s previous research has shown that:
She is now working to translate similar innovative approaches to care into community settings through collaborations with the OCHIN Practice-Based Research Network and two large health insurance plans that provide Medicaid insurance to low-income individuals and families.
She is also a core member of the Alliance for Reducing Cancer, Northwest, a collaborative team of cancer prevention and control experts and community stakeholders whose mission is build relationships between researchers and community partners, conduct cancer-related research, and translate research into community practice.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was as an associate editor for the American Journal of Preventive Medicine from 2009 to 2014. She is an editorial board member of the Journal of the American Board of Family Practice. She is also a fellow of the American Heart Association, an honor given for contributions to the field. Dr. Green has served as an associate clinical professor at the UW School of Medicine since 1992.
Nielson CM, Vollmer W, Petrik AF, Keast EM, Green BB, Coronado GD. Factors affecting adherence in a pragmatic trial of annual fecal immunochemical testing for colorectal cancer. J Gen Intern Med. 2019 Jan 25. doi: 10.1007/s11606-018-4820-0. [Epub ahead of print]. PubMed
Meenan RT, Coronado JD, Petrik AF, Green BB. A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics. Prev Med. 2019 Jan 24. pii: S0091-7435(19)30021-0. doi: 10.1016/j.ypmed.2019.01.014. [Epub ahead of print]. PubMed
Cohen JB, Padwal RS, Gutkin M, Green BB, Bloch MJ, Germino FW, Sica DA, Viera AJ, Bluml BM, White WB, Taler SJ, Yarows S, Shimbo D, Townsend RR. History and justification of a national blood pressure measurement validated device listing. Hypertension. 2018 Dec 24:HYPERTENSIONAHA11811990. doi: 10.1161/HYPERTENSIONAHA.118.11990. [Epub ahead of print]. PubMed
Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, Schwartz MR, Coronado GD. Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates. Transl Behav Med. 2018 Nov 16. pii: 5184635. doi: 10.1093/tbm/iby094. [Epub ahead of print]. PubMed
Green BB. Colorectal cancer control: where have we been and where should we go next? JAMA Intern Med. 2018 Oct 15. pii: 2706173. doi: 10.1001/jamainternmed.2018.4627. [Epub ahead of print]. PubMed
KPWHRI’s Kilian Kimbel reflects on how the SOS study helped pave the way for a new program to find colon cancer early.
Home blood pressure monitoring shown to be an excellent alternative for making new diagnoses of hypertension.
Research led by KPWHRI’s Beverly Green, MD, MPH, finds that patients prefer at-home monitoring of blood pressure.
VeryWell Health, March 16, 2022